Administration, Intravaginal
"Administration, Intravaginal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories.
| Descriptor ID |
D000282
|
| MeSH Number(s) |
E02.319.267.120.500
|
| Concept/Terms |
Administration, Intravaginal- Administration, Intravaginal
- Vaginal Administration
- Administrations, Vaginal
- Vaginal Administrations
- Administration, Vaginal
- Intravaginal Administration
- Administrations, Intravaginal
- Intravaginal Administrations
Instillation, Vaginal- Instillation, Vaginal
- Instillations, Vaginal
- Vaginal Instillation
- Vaginal Instillations
- Vaginal Drug Administration
- Drug Administration, Vaginal
- Administration, Vaginal Drug
- Administrations, Vaginal Drug
- Drug Administrations, Vaginal
- Vaginal Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Intravaginal".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intravaginal".
This graph shows the total number of publications written about "Administration, Intravaginal" by people in this website by year, and whether "Administration, Intravaginal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Intravaginal" by people in Profiles.
-
Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insert. Menopause. 2021 05 28; 28(9):998-1003.
-
Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy. Breast Cancer Res Treat. 2016 06; 157(2):203-210.
-
Use of misoprostol for management of unsatisfactory colposcopy in the adolescent: a case report and review of the literature. J Pediatr Adolesc Gynecol. 2009 Oct; 22(5):e139-41.
-
Innovations in contraception: a review. Clin Obstet Gynecol. 2007 Jun; 50(2):425-39.
-
Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques. J Virol. 2004 Jan; 78(2):841-54.
-
Misoprostol versus low-dose oxytocin for cervical ripening: a prospective, randomized, double-masked trial. Am J Obstet Gynecol. 2002 Aug; 187(2):273-9; discussion 279-80.
-
Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis. J Reprod Med. 1989 Jul; 34(7):479-83.
-
Patient acceptance of prefilled disposable vaginal applicator. Am J Obstet Gynecol. 1988 Apr; 158(4):1006-8.